Methods and compositions for detecting cancers associated with methylation of hMLH1 promoter DNA
AssigneeCase Western Reserve University
InventorsSanford Markowitz, William Grady
Life of this patent
Estimating the term…
Loading patent…
AssigneeCase Western Reserve University
InventorsSanford Markowitz, William Grady
Estimating the term…
Methods are provided for detection of cancers associated with methylation of hMLH1 promoter DNA in a subject. The method comprise assaying for the presence of methylated hMLH1 promoter DNA in a bodily fluid from a subject. In one embodiment, the method comprises reacting DNA from the sample with a chemical compound that converts non-methylated cytosine bases but not methylated cytosine bases, to a different nucleotide base. The compound-converted DNA is then amplified using a methylation-sensitive polymerase chain reaction (MSP) employing primers that amplify the compound-converted DNA template. The present invention also provides nucleotide primer sequences for use in the methylation-sensitive PCR assay.
A method for detecting the presence of a cancer associated with methylation of hMLH1 promoter DNA in a subject, comprising:
A method for monitoring over time a cancer associated with methylation of hMLH1 promoter DNA in a subject;
A method for monitoring response to therapy of a cancer associated with methylation of hMLH1 promoter DNA in a subject, comprising:
A detection method for prognosis of a cancer in a subject known to have or suspected of having a cancer associated with methylation of hMLH1 promoter DNA, comprising:
A detection method for prognosis of a cancer in a subject known to have or suspected of having a cancer associated with methylation of hMLH1 promoter DNA, comprising:
A primer set for detecting the presence of a cancer associated with methylation of hMHL1 promoter DNA in a subject;
Dependencies are inferred from the claim text.